Australia News
-
Rush Gene Service helps develop H7N9 vaccine
Australia | News | By BioSpectrum Bureau | 0 Comment | 09 Jul, 2013
Singapore: GenScript, global provider of synthetic genes, has collaborated with NASDAQ listed Novavax in developing an a...Read more
-
Avita Medical appoints Michael Perry to board
Australia | News | By BioSpectrum Bureau | 0 Comment | 07 Feb, 2013
Singapore: Regenerative medicine company Avita Medical, listed on ASX, has appointed Dr Michael S Perry, vice president ...Read more
-
Abortion pill among new drugs to be listed on PBS
Australia | News | By BioSpectrum Bureau | 0 Comment | 02 Jul, 2013
Singapore: Australia's federal health minister Ms Tanya Plibersek has revealed that drugs to treat skin cancer, as well ...Read more
-
Bluechiip, MiTeGen sign cryopins' licence deal
Australia | News | By BioSpectrum Bureau | 0 Comment | 06 Dec, 2012
Singapore: Bluechiip signed a license agreement with US-based high-technology manufacturing company, MiTeGen, for track...Read more
-
Seasonal wave of Meningococci begins in Australia
Australia | News | By BioSpectrum Bureau | 0 Comment | 17 Jun, 2014
Singapore: The deadly meningococcal disease that affects hundreds in Australia annually, has begun to show its presence ...Read more
-
GI Dynamics resolves litigation issues with Gore
Australia | News | By BioSpectrum Bureau | 0 Comment | 11 Jan, 2013
Singapore: GI Dynamics has reached a settlement with WL Gore & Associates in litigation brought by the latter in th...Read more
-
Micronic to distribute Bluechiip products
Australia | News | By BioSpectrum Bureau | 0 Comment | 15 Jan, 2013
Singapore: Bluechiip has signed a distribution agreement with Micronic America. The agreement gives Micronic America an...Read more
-
QRxPharma to resubmit NDA to FDA for pain relieving drug
Australia | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2014
Singapore: Australia's QRxPharma has received Complete Response Letter (CRL) from USFDA for its MOXDUO New Drug Applicat...Read more
-
Australia Day Honor for ex-Uniquest MD
Australia | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2014
Singapore: Dr David Evans AM was named a Member in the General Division of the Order of Australia on this year's Austra...Read more
-
Patrys offers human antibodies for cancer cure
Australia | News | By BioSpectrum Bureau | 0 Comment | 16 Mar, 2012
Traditionally, researchers have utilized rodents to generate antibodies that attack human cancer tissues. In most cases,...Read more
-
Lignol Energy acquires majority stake in ARW
Australia | News | By BioSpectrum Bureau | 0 Comment | 14 Feb, 2013
Singapore: Lignol Energy (LEC) announced its participation in a Private Placement and Rights Offering financing, underta...Read more
-
Aussie scientists discover Earth's oldest signs of life
Australia | News | By BioSpectrum Bureau | 0 Comment | 18 Nov, 2013
Singapore: The sedimentary rocks in the remote Pilbara region in Western Australia have proved to be a goldmine of knowl...Read more
-
Australia ideal for early-stage drug development
Australia | Opinion | By BioSpectrum Bureau | 0 Comment | 14 Jun, 2012
Australia has a long history in biomedical research, with a reputation for excellence and invention since the early 1900...Read more
-
UniQuest MD David Henderson to move on
Australia | News | By BioSpectrum Bureau | 0 Comment | 23 Jan, 2013
Singapore: UniQuest's Managing Director Mr David Henderson announced his decision to move into non-executive directorsh...Read more
-
Australia, Thailand to participate in NIH-sponsored trials
Australia | News | By BioSpectrum Bureau | 0 Comment | 06 Feb, 2013
Singapore: Three clinical trials that seek to find more effective treatments for influenza are enrolling volunteers with...Read more
-
Dr Joseph Horrigan appointed VP at Neuren
Australia | News | By BioSpectrum Bureau | 0 Comment | 13 Aug, 2012
Singapore: Neuren Pharmaceuticals has appointed Dr Joseph Horrigan as its vice president- Clinical Development and Medic...Read more
-
Aus pharma benefit scheme includes Parkinson's drug
Australia | News | By BioSpectrum Bureau | 0 Comment | 18 Jun, 2013
Singapore: The Australian Pharmaceutical Benefits Scheme has listed a novel treatment for Parkinson's disease in order t...Read more
-
ResMed to initiate quarterly dividend in 2013
Australia | News | By BioSpectrum Bureau | 0 Comment | 21 May, 2012
Singapore: ResMed plans to initiate a quarterly dividend of $0.17 per share during the first quarter of its fiscal 2013,...Read more
